Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. [electronic resource]
- Stem cells and development Apr 2010
- 557-68 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-8534
10.1089/scd.2009.0147 doi
Biomarkers Bone Morphogenetic Protein Receptors--genetics Cell Differentiation--drug effects Cell Line Chromones--pharmacology Core Binding Factor Alpha 1 Subunit--genetics Embryonic Stem Cells--cytology Enzyme Inhibitors--pharmacology Homeodomain Proteins--genetics Humans Immunosuppressive Agents--pharmacology Inhibitor of Differentiation Protein 1--genetics Intracellular Signaling Peptides and Proteins--antagonists & inhibitors Morpholines--pharmacology Nanog Homeobox Protein Octamer Transcription Factor-3--genetics Osteoblasts--cytology Osteogenesis--drug effects Phosphatidylinositol 3-Kinases--metabolism Phosphoinositide-3 Kinase Inhibitors Protein Serine-Threonine Kinases--antagonists & inhibitors Proto-Oncogene Proteins c-akt--antagonists & inhibitors RNA, Messenger Ribosomal Protein S6 Kinases, 70-kDa--metabolism Signal Transduction--drug effects Sirolimus--pharmacology Smad Proteins--metabolism TOR Serine-Threonine Kinases Tacrolimus--pharmacology